Research Article
Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer
Table 5
Correlation between serum CA125 level and clinicopathological factors.
| | Characteristic | CA125 negative () | CA125 positive () | value |
| | Age (years) | | | 0.1674 | | <50 | 423 (93.17) | 31 (6.83) | | | ≥50 | 483 (95.27) | 24 (4.73) | | | Histologic grade | | | 0.6247 | | Grade 1 | 65 (92.86) | 5 (7.14) | | | Grade 2 | 558 (94.74) | 31 (5.26) | | | Grade 3 | 191 (93.17) | 14 (6.83) | | | Tumor size (cm) | | | 0.0296 | | <2 | 494 (95.74) | 22 (4.26) | | | ≥2 | 353 (92.17) | 30 (7.83) | | | Node status | | | 0.0157 | | N0 | 487 (95.87) | 21 (4.13) | | | N1 | 374 (91.89) | 33 (8.11) | | | ER | | | 0.0825 | | Negative | 231 (92.03) | 20 (7.97) | | | Positive | 675 (95.07) | 35 (4.93) | | | PR | | | 0.0341 | | Negative | 268 (91.78) | 24 (8.22) | | | Positive | 638 (95.37) | 31 (4.63) | | | Her2 | | | 0.5191 | | Negative | 681 (93.93) | 44 (6.07) | | | Positive | 225 (95.34) | 11 (4.66) | | | Ki67 (%) | | | | | <14 | 244 (94.94) | 13 (5.06) | 0.5855 | | ≥14 | 660 (94.02) | 42 (5.98) | | | Molecular subtype | | | 0.2605 | | Luminal A | 213 (95.09) | 11 (4.91) | | | Luminal B1 | 363 (94.53) | 21 (5.47) | | | Luminal B2 | 121 (95.28) | 6 (4.72) | | | Her2 overexpression | 104 (95.41) | 5 (4.59) | | | Triple-negative | 105 (89.74) | 12 (10.26) | |
|
|
|
